RxDoctor Payments Data

Jennifer Jones, APRN

Family · Morristown, TNNPI 1114393089

Payments from drug & device makers

$7,566in general payments, 2019–2025

Across 512 payments — averaging $14.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • GSK$635
  • Pfizer$322
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$290
  • Sumitomo Pharma America, Inc.$286
  • plus $4K from 46 others

What the payments were for

  • Food & beverage$7,566100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,566 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$126,490
Medicare patients
239
Services billed
7,504

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide228$296,067
EliquisApixaban210$196,115
Trelegy ElliptaFluticasone/Umeclidin/Vilanter194$164,595
XareltoRivaroxaban101$93,724
JardianceEmpagliflozin85$88,518
Humira PenAdalimumab11$74,626
TrulicityDulaglutide67$71,466
MounjaroTirzepatide60$67,412
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog63$57,015
Soliqua 100-33Insulin Glargine/Lixisenatide62$53,536
MyrbetriqMirabegron52$48,515
RybelsusSemaglutide34$48,291
Tresiba Flextouch U-200Insulin Degludec22$46,732
JanuviaSitagliptin Phosphate45$45,865
LinzessLinaclotide43$45,728

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,084$344,357262 claims
PfizerEliquis$322$196,115210 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy$635$188,656246 claims
Lilly USA, LLCTrulicity, Mounjaro$46$138,878127 claims
Boehringer IngelheimJardiance, Glyxambi$44$106,10098 claims
AbbVieLinzess, Vraylar, Ubrelvy$1,036$98,22974 claims
Johnson & JohnsonXarelto$249$93,724101 claims
MerckJanuvia, Janumet, Belsomra$30$68,45278 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$243$63,76399 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$208$53,53662 claims
Astellas Pharma US IncMyrbetriq$188$48,51552 claims
Otsuka America Pharmaceutical, Inc.Rexulti$97$29,34615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.

Other family in Morristown

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →